We found that a few genes identified by MSG had been reported to influence schizophrenia risk via splicing (Note 1 Section 1C in S1 Appendix), including SNX19 [56], AS3MT [57], and CYP2D6 [56] (Fig 6C). This evidence concerns the gene SNX19 and schizophrenia.